Background Calcium binding protein 4 (CABP4), specifically located in photoreceptor synaptic terminals, has been associated with congenital stationary night blindness based on this clinical diagnosis being made for three individuals from two Swiss families with CABP4 mutations; however, the few reported cases limit phenotype-genotype correlation. We expand the number of reported patients with CABP4 mutations and clinically characterise the CABP4-related phenotype. Methods A retrospective case series of 11 individuals (age 2-26 years; four consanguineous families) with early-onset retinal dysfunction found to harbour CABP4 mutations after a strategy of homozygosity analysis and/or candidate gene testing.
INTRODUCTION
Calcium binding protein 4 (CABP4), a member of the CABP family of neuronal Ca 2+ -binding proteins, is specifically located in photoreceptor synaptic terminals, where it probably modulates photoreceptor Ca 2+ channels and transmitter release. 12 Because there are only a few reported patients harbouring CABP4 mutations, phenotypegenotype correlation is limited. [3] [4] [5] Affected individuals have been labelled as incomplete congenital stationary night blindness (CSNB; two families), 3 congenital cone-rod synaptic disorder (one family) 4 and Leber congenital amaurosis-like (one family). 5 In order to characterise the associated clinical phenotype better, we report the ophthalmic findings of additional identified patients harbouring CABP4 mutations in the context of clinical features that have been described in previous reports. [3] [4] [5] 
METHODS
Institutional review board approval was granted for this study. Patients with early-onset retinal dysfunction whose phenotypes segregated with recessive CABP4 mutations were identified and reviewed. These CABP4 mutations were identified in consanguineous Saudi families with early-onset retinal dysfunction who were referred for genetic testing. A previously described strategy 6 of homozygosity analysis to identify candidate genes for sequencing was used for all but the final family; for that final family the affected individual directly underwent CABP4 gene testing because by that time we had become familiar with recurrent clinical features of the CABP4-related phenotype. All affected family members underwent complete ophthalmic examination including cycloplegic refraction (cyclopentolate 1%) and most had full-field electroretinography (ERG) as per the standards of the International Society for Clinical Electrophysiology of Vision. 7 Primers and PCR conditions used for CABP4 sequencing are available in supplementary tables 1 and 2 (available online only). Affected individuals from all four families underwent haplotype analysis of a recurrent mutation. For haplotype analysis, the GeneChip Human Mapping 2 × 250K (500K) Array Set (Affymetrix, Santa Clara, CA) was used in conjunction with GeneChip Genotyping Analysis Software (Affymetrix, Santa Clara, CA). Relevant SNPs were selected which span a 3 Mb region (65,526,356-68,767,227) that includes the CABP4 gene.
RESULTS
A homozygous c.81_82insA CABP4 mutation ( p. Pro28Thrfs*4; accession number NM_145200.3) segregated with congenital retinal dysfunction in 11 affected individuals (aged 2-26 years) from four consanguineous families (family A: four affected siblings; family B: three affected siblings; family C: two affected siblings and their affected mother; family D: an affected boy) (table 1) . Family A has previously been reported. 5 Haplotype analysis confirmed a shared haplotype surrounding the mutation for all four families (supplementary table 3, available online only).
Clinical features are summarised in table 1. All 11 patients had congenital nystagmus, low vision that was considered stable and photophobia. No patient complained of night blindness, and all patients had been specifically questioned for this potential symptom. For all patients fundus appearance was normal or near normal. Eight were All patients had normal or near-normal fundus examination. All patients had nystagmus, photophobia and no night blindness except for patient 3 (family 2), the only patient with a missense mutation. In a given family, affected individuals are siblings except for family 6 (patient 13 is the mother in a pseudodominant pedigree). BCVA, best-corrected visual acuity; CF, count fingers; CRSD, cone-rod synaptic disorder; CSM, central steady maintained; CSNB, congenital stationary night blindness; ID, patient identification number; LCA, Leber congenital amaurosis; NA, not available.
hyperopic (≥+1.00 dioptre spherical equivalent). In family A (the previously reported family), 5 three of the four affected family members had ERGs that were non-recordable. The fourth affected family member from family A and all affected individuals from families B and C had similar ERGs: an electronegative waveform to scotopic flash, near-normal or subnormal rod function and decreased and delayed cone responses to photopic flash (figure 1).
A review of the phenotypes of the previously reported Swiss and Dutch patients with CABP4 mutations revealed all but one patient (the only reported compound heterozygote harbouring the only reported missense mutation) 3 to have similar clinical features and symptoms (table 1) . ERGs in the current study and previous reports [3] [4] [5] were similar with the exception of the three affected individuals from family A with non-recordable ERG tracings (table 1) .
DISCUSSION
Despite different clinical diagnoses, previously reported Swiss and Dutch patients with homozygous CABP4 mutations and these Saudi patients harbouring a homozygous c.81_82ins1 mutation had similar clinical features, and none complained of night blindness. When recordable, the ERG showed cone-rod dysfunction with an electronegative waveform response to scoptopic flash. Rather than CSNB, the CABP4-related phenotype is better uniformly considered congenital cone-rod synaptic disorder, the term that was used to describe the previously-reported Dutch family.
The first three reported patients (from two Swiss families) were clinically labelled as incomplete CSNB and were found to harbour mutations in CABP4 after it was sequenced as a candidate gene because of its known function in the photoreceptor synapse (table 1) . 3 In the two patients who were siblings a homozygous c.800_801del2 was found, predicted to cause a frameshift and elongation of the protein by 96 amino acids ( p.Glu267fs) that probably disrupted its tertiary structure and interactions. 3 The third patient was compound heterozygous for the same mutation with a missense variant (c.370C>T) that was predicted to be functionally damaging to protein function. 3 There seem to have been two factors that led Zeitz et al 3 to label these three patients as CSNB. One is that they had an electronegative ERG, a classic (although not specific) feature of CSNB. The other is the fact that mutations in another CABP protein gene at the photoreceptor synapse-CACNA1F-are a recognised cause of incomplete CSNB (in which both rods and cones are affected on the ERG, as was the case in the these three patients, as opposed to rods only in complete CSNB). 8 However, in these three Swiss patients cones were more affected than rods (rather than rods being more affected than cones), and only one of the three complained of night blindness when specifically questioned. That one patient is the only reported patient with CABP4 mutations with this symptom. He is also atypical from other reported patients with CABP4 mutations in other waysin addition to having the symptom of night blindness, he is the only one with compound heterozygosity, a missense CABP4 variant, visual acuity as good as 20/30, symptoms of progressive visual loss and no nystagmus (table 1) . 3 In the context of all other described patients [3] [4] [5] and the new patients reported in this study, his phenotype is not characteristic of CABP4 mutations (table 1) .
The third and fourth reported patients (siblings from a Dutch family) were found to harbour the homozygous CABP4 mutation (c.646C>T;p.Arg216X) after homozygosity mapping and subsequent candidate gene analysis (table 1) . 4 Although these Dutch siblings had electronegative ERGs that resembled what is seen in incomplete CSNB, Littink et al 4 recognised that cones were more severely affected than rods, that the isolated rod response was near normal or subnormal, and that neither patient had the symptom of night blindness. In light of these observations and the localisation of CABP4, the authors felt the best term for the phenotype was cone-rod synaptic disorder.
In the current study, 11 Saudi patients (four consanguineous families) harboured the same underlying homozygous c.81_82insA CABP4 mutation. Family A was previously described as Leber congenital amaurosis-like 5 based on nonrecordable ERG tracings in three of the four affected family members. Clinically, however, these patients had features and symptoms similar to those of all other patients with homozygous CABP4 mutations-congenital nystagmus, low vision that was considered stable, photophobia, no night blindness symptoms, a normal or near-normal fundus appearance and a typically hyperopic refraction (table 1), which suggests that the low ERG readings in family A were related to the severity of the condition rather than a disease entity different from that of other affected patients. Supporting this concept is the fact that the one affected family member from family A who had a recordable ERG ( patient 8 in table 1) and all affected individuals from families B, C and D ( patients 10-16 in table 1) had ERG tracings similar to each other and to those of all other previously reported CABP4-related patients: cone-rod dysfunction and an electronegative waveform response to scotopic flash (table 1, figure 1) . Our findings in these new cases and reappraisal of previously described cases define the phenotype that should raise suspicion for CABP4 mutations. Homozygous loss-of-function CAPB4 mutations cause a relatively stable congenital cone-rod dysfunction with congenital nystagmus and a normal or near-normal fundus appearance. Affected individuals do not complain of night blindness and are usually hyperopic. When recordable the ERG shows an electronegative response to scotopic flash in the setting of cone-rod dysfunction. As has been previously suggested, 4 this phenotype is best uniformly termed congenital cone-rod synaptic disorder. In Saudi Arabia, a founder homozygous c.81_82insA CABP4 mutation is a recurrent cause.
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